Status:
COMPLETED
Improvement in Bronchial Asthma in Patients With Extraesophageal Reflux After Acid Suppression
Lead Sponsor:
Ponce Gastroenterology Research
Collaborating Sponsors:
PriCara, Unit of Ortho-McNeil, Inc.
Conditions:
Bronchial Asthma
Gastroesophageal Reflux
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine if 20mg BID of Rabeprazole is effective in controlling GERD in patients with concomitant bronchial asthma and to assess improvement in asthma after reflux con...
Detailed Description
Gastroesophageal Reflux Disease has been considered as having a role in the course of asthma, as shown by the improvement of symptoms with adequate acid suppression therapy. It is important to conside...
Eligibility Criteria
Inclusion
- Moderate Persistent or moderate severe bronchial asthma as determined by the study pulmonologist
- Gastroesophageal Reflux disease
Exclusion
- History of hypersensitivity to rabeprazole or its metabolites
Key Trial Info
Start Date :
July 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00234117
Start Date
July 1 2005
Last Update
July 22 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ponce Gastroentrology Research
Ponce, Puerto Rico, 00717